B2B
Sequenta
United Statessequent.app
Sequenta develops the LymphoSIGHT platform that analyzes adaptive immune system diversity to monitor minimal residual disease, enabling improved clinical diagnostics and patient care.
series-a
series-a
Stage
1
Funding Rounds
About
Sequenta develops the LymphoSIGHT platform that analyzes adaptive immune system diversity to monitor minimal residual disease, enabling improved clinical diagnostics and patient care.
Explore Sequenta's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.